Characterization of a re‐engineered, mesothelin‐targeted<i>Pseudomonas</i>exotoxin fusion protein for lung cancer therapyFrieder Bauss, Gerhard Niederfellner, Ben‐Fillippo Krippendorff et al.|Molecular Oncology|2016Cited by 56